Importance of schedule of administration of adjunctive, short-term immunosuppression in ALS- and bone marrow cell-treated, skin-allografted mice.
Gozzo
J J
JJ
Bouvé College of Pharmacy and Health Sciences, Northeastern University, Boston, MA 02115.
Plowey
J
J
Hartner
W C
WC
De Fazio
S R
SR
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D015704:CD4 Antigens / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D017690:Cell Transplantation; D004334:Drug Administration Schedule; D006146:Guanidines / Q000008:administration & dosage / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D011090:Polyenes / Q000008:administration & dosage / Q000627:therapeutic use; D020123:Sirolimus; D016038:Skin Transplantation / Q000276:immunology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015704:CD4 Antigens; D016827:CD8 Antigens; D006146:Guanidines; D007166:Immunosuppressive Agents; D011090:Polyenes; C037258:gusperimus; D020123:Sirolimus